Cost of Hemodialysis Treatment and Associated Factors Among End-Stage Renal Disease Patients at the Tertiary Hospitals of Addis Ababa City and Amhara Region, Ethiopia

References

• Yeates K, Ghosh S, Kilonzo K. Developing nephrology programs in very low-resource settings: challenges in sustainability. Kid Int Suppl. 2013;3(2):202–205. doi:10.1038/kisup.2013.14
   Web of Science ®Google Scholar
• Ssystem URD. USRDS 2008 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008.
   Google Scholar
• Gerogianni S, Babatsikou F, Gerogianni G, et al. Concerns of patients on dialysis: a research study. Health Sci J. 2014;8(4):423.
   Google Scholar
• Naicker S, Ashuntantang G. End stage renal disease in sub-Saharan Africa. In: Chronic Kidney Disease in Disadvantaged Populations. Elsevier; 2017:125–137.
   Google Scholar
• Fiseha T, Kassim M, Yemane T. Prevalence of chronic kidney disease and associated risk factors among diabetic patients in southern Ethiopia. Am J Health Res. 2014;2(4):216–221. doi:10.11648/j.ajhr.20140204.28
   Google Scholar
• Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–1982. doi:10.1016/S0140-6736(14)61601-9
   PubMed Web of Science ®Google Scholar
• McDonald SP, Russ GR. Burden of end-stage renal disease among indigenous peoples in Australia and New Zealand. Kidney Int. 2003;63:S123–S127. doi:10.1046/j.1523-1755.63.s83.26.x
   Web of Science ®Google Scholar
• Lakshmi K, Nagesh Y, Krishna MV. Performance comparison of three data mining techniques for predicting kidney dialysis survivability. Int J Adv Eng Technol. 2014;7(1):242.
   Google Scholar
• Chang Y-T, Hwang J-S, Hung S-Y, et al. Cost-effectiveness of hemodialysis and peritoneal dialysis: a national cohort study with 14 years follow-up and matched for comorbidities and propensity score. Sci Rep. 2016;6(1):1–12. doi:10.1038/s41598-016-0001-8
   PubMed Web of Science ®Google Scholar
• Ghimire S, Castelino RL, Lioufas NM, Peterson GM, Zaidi STR, Chilcot J. Nonadherence to medication therapy in haemodialysis patients: a systematic review. PLoS One. 2015;10(12):12. doi:10.1371/journal.pone.0144119
   Web of Science ®Google Scholar
• Ranasinghe P, Perera YS, Makarim MF, Wijesinghe A, Wanigasuriya K. The costs in provision of haemodialysis in a developing country: a multi-centered study. BMC Nephrol. 2011;12(1):42. doi:10.1186/1471-2369-12-42
   Web of Science ®Google Scholar
• Just PM, Riella MC, Tschosik EA, Noe LL, Bhattacharyya SK, de Charro F. Economic evaluations of dialysis treatment modalities. Health Policy. 2008;86(2–3):163–180. doi:10.1016/j.healthpol.2007.12.004
   Web of Science ®Google Scholar
• Prabahar M, Chandrasekaran V, Soundararajan P. Epidemic of chronic kidney disease in India -what can be done? Saudi J Kidney Dis Transpl. 2008;19(5):847–853.
   PubMedGoogle Scholar
• Grassmann A, Gioberge S, Moeller S, Brown G. ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends. Nephrol Dial Transplant. 2005;20(12):2587–2593. doi:10.1093/ndt/gfi159
   PubMed Web of Science ®Google Scholar
• Collins AJ, Foley RN, Chavers B, et al. United States renal data system 2011 annual data report: atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2012;59(1Suppl 1):A7, e1–420.
   Google Scholar
• Bruns FJ, Seddon P, Saul M, Zeidel ML. The cost of caring for end-stage kidney disease patients: an analysis based on hospital financial transaction records. J Am Soc Nephrol. 1998;9(5):884–890.
   Web of Science ®Google Scholar
• Pacheco A, Saffie A, Torres R, et al. Cost/utility study of peritoneal dialysis and hemodialysis in Chile. Perit Dial Int. 2007;27(3):359–363. doi:10.1177/089686080702700328
   Web of Science ®Google Scholar
• de Abreu MM, Walker DR, Sesso RC, Ferraz MB. A cost evaluation of peritoneal dialysis and hemodialysis in the treatment of end-stage renal disease in Sao Paulo, Brazil. Perit Dial Int. 2013;33(3):304–315. doi:10.3747/pdi.2011.00138
   Web of Science ®Google Scholar
• Villa G, Fernández–Ortiz L, Cuervo J, et al. Cost-effectiveness analysis of the Spanish renal replacement therapy program. Perit Dial Int. 2012;32(2):192–199. doi:10.3747/pdi.2011.00037
   Web of Science ®Google Scholar
• Kontodimopoulos N, Niakas D. An estimate of lifelong costs and QALYs in renal replacement therapy based on patients’ life expectancy. Health Policy. 2008;86(1):85–96. doi:10.1016/j.healthpol.2007.10.002
   Web of Science ®Google Scholar
• Lorenzo V, Perestelo L, Barroso M, Torres A, Nazco J. Economic evaluation of haemodialysis. Analysis of cost components based on patient-specific data. Nefrología. 2010;30(4):403–412.
   Web of Science ®Google Scholar
• Okafor C, Kankam C. Future options for the management of chronic kidney disease in Nigeria. Gend Med. 2012;9(1):S86–S93. doi:10.1016/j.genm.2011.10.002
   PubMedGoogle Scholar
• Matri A, Elhassan E, Abu-Aisha H. Renal replacement therapy resources in Africa. Arab J Nephrol Transplant. 2008;1(1):9–14.
   Google Scholar
• Elsharif ME, Gariballa EE, Gadour M. Costs of hemodialysis and kidney transplantation in Sudan A single center experience. 2010.
   Google Scholar
• Grün RP, Constantinovici N, Normand C, Lamping DL. Costs of dialysis for elderly people in the UK. Nephrol Dial Transplant. 2003;18(10):2122–2127. doi:10.1093/ndt/gfg354
   Web of Science ®Google Scholar
• Icks A, Haastert B, Gandjour A, et al. Costs of dialysis—a regional population-based analysis. Nephrol Dial Transplant. 2010;25(5):1647–1652. doi:10.1093/ndt/gfp672
   PubMed Web of Science ®Google Scholar
• de Wit GA, Merkus MP, Krediet RT, de Charro FT. Health profiles and health preferences of dialysis patients. Nephrol Dial Transplant. 2002;17(1):86–92. doi:10.1093/ndt/17.1.86
   Web of Science ®Google Scholar
• Suja A, Anju R, Anju V, Neethu J, Peeyush P, Saraswathy R. Economic evaluation of end stage renal disease patients undergoing hemodialysis. J Pharm Bioallied Sci. 2012;4(2):107. doi:10.4103/0975-7406.94810
   PubMedGoogle Scholar
• Ekrikpo UE, Udo AI, Ikpeme EE, Effa EE. Haemodialysis in an emerging centre in a developing country: a two year review and predictors of mortality. BMC Nephrol. 2011;12(1):50. doi:10.1186/1471-2369-12-50
   Web of Science ®Google Scholar
• Cherchiglia ML, Machado EL, Szuster DAC, et al. Epidemiological profile of patients on renal replacement therapy in Brazil, 2000–2004. Rev Saude Publica. 2010;44:639–649. doi:10.1590/S0034-89102010000400007
   PubMed Web of Science ®Google Scholar
• Birara D. Reflections on the Health Insurance Strategy of Ethiopia. 2018. Available from: https://www.researchgate.net/publication/323551458_Reflections_on_the_Health_Insurance_Strategy_of_Ethiopia.
   Google Scholar
• Shaikh M, Woodward M, John O, et al. Utilization, costs, and outcomes for patients receiving publicly funded hemodialysis in India. Kidney Int. 2018;94(3):440–445. doi:10.1016/j.kint.2018.03.028
   Web of Science ®Google Scholar
• Kaur G, Prinja S, Ramachandran R, Malhotra P, Gupta KL, Jha V. Cost of hemodialysis in a public sector tertiary hospital of India. Clin Kidney J. 2018;11(5):726–733. doi:10.1093/ckj/sfx152
   Web of Science ®Google Scholar
• Gilardino RE, Gonzalez-Pier E, Brabata C. End-stage renal disease models in the Americas: optimizing resources to achieve better health outcomes. Value Health Reg Issues. 2018;17:115–118. doi:10.1016/j.vhri.2018.04.001
   Google Scholar
• Golestaneh L, Alvarez PJ, Reaven NL, et al. All-cause costs increase exponentially with increased chronic kidney disease stage. Am J Manag Care. 2017;23(10 Suppl):S163–S172.
   PubMed Web of Science ®Google Scholar
• Gao A, Osgood ND, Jiang Y, Dyck RF. Projecting prevalence, costs and evaluating simulated interventions for diabetic end stage renal disease in a Canadian population of aboriginal and non-aboriginal people: an agent based approach. BMC Nephrol. 2017;18(1):283. doi:10.1186/s12882-017-0699-y
   Web of Science ®Google Scholar
• Etheredge H, Fabian J Challenges in expanding access to dialysis in South Africa—expensive modalities, cost constraints and human rights. Paper presented at: Healthcare; 2017.
   Google Scholar
• Yang F, Lau T, Luo N. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore. Nephrology (Carlton). 2016;21(8):669–677. doi:10.1111/nep.12668
   Web of Science ®Google Scholar
• Naoum P, Topkaroglou I, Kitsonis D, et al. Cost calculations during “dire straits”: a cost-of-illness analysis of regular hemodialysis for end-stage renal disease in Greece. Int J Artif Organs. 2016;39(2):87–89. doi:10.5301/ijao.5000477
   Web of Science ®Google Scholar
• Takura T. Cost-effectiveness of hemodialysis in Japan. Contrib Nephrol. 2015;185:124–131.
   Web of Science ®Google Scholar
• Mushi L, Marschall P, Fleßa S. The cost of dialysis in low and middle-income countries: a systematic review. BMC Health Serv Res. 2015;15(1):506. doi:10.1186/s12913-015-1166-8
   Web of Science ®Google Scholar
• Chang Y-K, Hsu -C-C, Chen P-C, et al. Trends of cost and mortality of patients on haemodialysis with end stage renal disease. Nephrology (Carlton). 2015;20(4):243–249. doi:10.1111/nep.12380
   Web of Science ®Google Scholar
• Holtgrave DR. Handbook of Economic Evaluation of HIV Prevention Programs. Springer Science & Business Media; 1998.
   Google Scholar
• Peeters P, Rublee D, Just PM, Joseph A. Analysis and interpretation of cost data in dialysis: review of Western European literature. Health Policy. 2000;54(3):209–227. doi:10.1016/S0168-8510(00)00112-3
   Web of Science ®Google Scholar
• Letsios A. The effect of the expenditure increase in the morbidity and the mortality of patients with end stage renal disease: the USA case. Hippokratia. 2011;15(Suppl 1):16.
   Google Scholar
• Rutstein SO The DHS wealth index: approaches for rural and urban areas. DHS working papers; 2008.
   Google Scholar
• Malehi AS, Pourmotahari F, Angali KA. Statistical models for the analysis of skewed healthcare cost data: a simulation study. Health Econ Rev. 2015;5(1):11. doi:10.1186/s13561-015-0045-7
   PubMed Web of Science ®Google Scholar
• Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the Economic Evaluation of Health Care Programmes. Oxford university press; 2015.
   Google Scholar
• Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic Evaluation in Clinical Trials. OUP Oxford; 2014.
   Google Scholar
• Jones AM. Models for Health Care. University of York, Centre for Health Economics; 2010.
   Google Scholar
• Moran JL, Solomon PJ, Peisach AR, Martin J. New models for old questions: generalized linear models for cost prediction. J Eval Clin Pract. 2007;13(3):381–389. doi:10.1111/j.1365-2753.2006.00711.x
   PubMed Web of Science ®Google Scholar
• Blough DK, Ramsey SD. Using generalized linear models to assess medical care costs. Health Serv Outcomes Res Methodol. 2000;1(2):185–202. doi:10.1023/A:1012597123667
   Google Scholar
• Prodjosudjadi W. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia. Ethn Dis. 2006;16(2):S2.
   Web of Science ®Google Scholar
• Zambrowski -J-J. Cost of dialysis in France. Nephrol Ther. 2016;12(Suppl 1):S95–S97. doi:10.1016/j.nephro.2016.02.002
   Google Scholar
• Manns B, Lee H, Taub K, Dean S, Johnson D, Donaldson C. Cost Analysis of Ongoing Care of Patients with End-Stage Renal Disease: What are the Important Determinants? Edmonton (AB): Alberta Centre for Health Services Utilization Research; 2003.
   Google Scholar